Health Uses: Morphine is a cornerstone for managing moderate to severe acute or chronic pain, particularly in palliative care, oncology, and sickle cell vaso-occlusive crises. Codeine treats mild-to-moderate pain and cough, often combined with acetaminophen or NSAIDs.
Clinical Literature Review: StatPearls (NCBI) highlights morphine's FDA-approved indications for pain, with pharmacokinetics showing rapid onset and key contraindications like respiratory depression. CDC guidelines emphasize its role in chronic pain but warn of risks like dependence. A PMC narrative review on topical morphine supports efficacy for ulcers, erosions, and lesions, with negligible systemic absorption. PubMed reviews confirm morphine's utility in cancer pain, reducing nonfatal MI by 28% and vascular death by 15% in meta-analyses. For codeine, StatPearls notes its use in pain and cough, with doses up to 60 mg effective but less so than non-opioids in postoperative settings. Cochrane reviews show codeine 60 mg inferior to ibuprofen/paracetamol combinations for acute pain. PMC systematic reviews affirm low-dose codeine safety in combinations, with rare addiction if dosed properly.
Health Uses: Digoxin treats heart failure and controls ventricular rate in atrial fibrillation. Digitoxin shares similar cardiac indications but is less commonly used due to longer half-life.
Clinical Literature Review: PMC meta-analysis of observational and trial data shows digoxin reduces heart failure hospitalizations but has neutral mortality effects; safety concerns include arrhythmias. DrugBank details digoxin's inotropic and chronotropic actions, with narrow therapeutic window requiring monitoring. PMC review traces digoxin's history and efficacy in arrhythmias, noting declines due to toxicity risks. StatPearls emphasizes its role in mild-moderate heart failure and bradycardia reversal. For digitoxin, PubMed pharmacokinetics highlight its longer half-life; PMC discusses its cardiac glycoside similarities to digoxin, with limited modern trials but historical use in heart failure.
Health Uses: Paclitaxel is a chemotherapy agent for ovarian, breast, lung, and other cancers, often in combination regimens.
Clinical Literature Review: StatPearls reviews its microtubule stabilization, with indications for advanced cancers; adverse effects include neuropathy. PMC updated pharmacokinetics shows nonlinear clearance at high doses, supporting 175 mg/m² as standard. PMC TDM recommendations endorse monitoring for NSCLC. PubMed clinical trials confirm efficacy in breast and ovarian cancers, with meta-analyses showing survival benefits but toxicity concerns.
Health Uses: Salicylic acid treats pain, fever, inflammation; aspirin extends to cardiovascular prevention and antiplatelet therapy.
Clinical Literature Review: PMC historical review credits willow bark for aspirin's origins, with salicin converting to salicylic acid for analgesia. PubMed meta-analyses show aspirin's CVD risk reduction (12% in events). StatPearls details aspirin's COX inhibition for pain and thrombosis prevention. PMC umbrella review confirms aspirin's primary prevention benefits outweigh bleeding risks in select groups.
Health Uses: Colchicine treats acute gout flares, prevents gout, and manages familial Mediterranean fever; off-label for pericarditis.
Clinical Literature Review: PMC update reviews anti-inflammatory mechanisms via microtubule inhibition. StatPearls notes FDA approval for gout and fever, with dosing caveats for renal impairment. PMC meta-analysis supports cardiovascular benefits in CAD, reducing events by 25%. PubMed trials confirm efficacy in pericarditis prophylaxis.
Health Uses: Vincristine treats leukemia, lymphoma, neuroblastoma; vinblastine for Hodgkin lymphoma, testicular cancer.
Clinical Literature Review: StatPearls details vincristine's antimitotic action, with neuropathy as key toxicity. PMC reviews liposomal formulations improving efficacy in ALL. For vinblastine, DrugBank notes its role in Hodgkin and lung cancers; PubMed trials show combination benefits but myelosuppression risks.
Health Uses: Quinine treats chloroquine-resistant malaria; off-label for leg cramps (not recommended due to risks).
Clinical Literature Review: DrugBank outlines quinine's antimalarial action via hemozoin disruption. PMC systematic review confirms efficacy in severe malaria but inferior to artemisinins. PubMed meta-analyses show reduced recrudescence but QT prolongation risks.
Health Uses: Ergotamine treats acute migraine; ergometrine prevents postpartum hemorrhage.
Clinical Literature Review: PubMed consensus reviews ergotamine's vasoconstrictive migraine relief, superior to placebo but inferior to triptans. For ergometrine, PMC cases highlight myocardial ischemia risks in anemia; WHO guidelines support its PPH role despite hypertension contraindications.
Health Uses: Ephedrine treats hypotension during anesthesia and nasal decongestion.
Clinical Literature Review: StatPearls details sympathomimetic actions for perioperative hypotension. PMC reviews confirm efficacy but cardiovascular risks; banned in supplements due to adverse events.
Health Uses: Atropine reverses bradycardia and organophosphate poisoning; scopolamine prevents motion sickness and PONV.
Clinical Literature Review: StatPearls reviews atropine's anticholinergic bradycardia reversal. PMC meta-analysis supports scopolamine for motion sickness prevention. PubMed confirms both's roles in emergencies but toxicity risks.
Health Uses: Physostigmine reverses anticholinergic toxicity and treats glaucoma.
Clinical Literature Review: PMC retrospective review shows safety in delirium reversal (96% agitation control). StatPearls notes contraindications in TCA overdose; effective at <2 mg doses.
Health Uses: Ouabain treats acute heart failure (historical IV use in some regions).
Clinical Literature Review: DrugBank details Na/K-ATPase inhibition for inotropy. PMC reviews cardioprotective effects in ischemia; limited modern trials due to toxicity.
Health Uses: Reserpine treats hypertension as second-line therapy.
Clinical Literature Review: PMC trial shows 0.1 mg efficacy in refractory hypertension. Cochrane review confirms BP reduction but depression risks; historical antipsychotic use declined.
Health Uses: None therapeutic; research for immunotoxins in cancer.
Clinical Literature Review: PubMed reviews toxicity mechanisms (ribosome inactivation); PMC discusses vaccine development; no approved uses due to lethality.
Health Uses: Psilocybin treats treatment-resistant depression and anxiety in trials.
Clinical Literature Review: PMC meta-analysis shows rapid antidepressant effects. PubMed reviews confirm efficacy in end-of-life anxiety; ongoing trials for addiction.
Health Uses: THC for nausea/appetite in chemotherapy/AIDS; CBD for epilepsy (Lennox-Gastaut, Dravet).
Clinical Literature Review: PMC reviews THC's antiemetic efficacy; StatPearls confirms CBD's seizure reduction (45-84%). Meta-analyses support chronic pain benefits but mixed psychiatric evidence.
Health Uses: None; historical stimulant, now pesticide.
Clinical Literature Review: StatPearls details glycine antagonism causing convulsions; no therapeutic role due to toxicity; rare in homeopathy at ultra-low doses.